Quinoline Binding Site on Malaria Pigment Crystal: A Rational Pathway for Antimalaria Drug Design

Crystal Growth and Design

Volumn 2, Issue 6, 2002, Pages 553-562

  Buller, Ronit ^a   Peterson, Matthew L ^b   Almarsson, Örn ^b   Leiserowitz, Leslie ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TransForm Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042139505     PISSN: 15287483     EISSN: None     Source Type: Journal    
DOI: 10.1021/cg025550i     Document Type: Article

References (78)

1. Bouland, P. B. Drug Resistance in Malaria; World Health Organization: Switzerland, 2001.
2. Kirk, K. Physiol. Rev. 2001, 81, 495-537.
3. Olliaro, P. Pharmacol. Ther. 2001, 89, 207-219.
4. Ziegler, J.; Linck, R.; Wright, D. W. Curr. Med. Chem. 2001, 8, 171-189.
5. Ginsburg, H. http://sites.huji.ac.il/malaria/, 2002.
6. Egan, T. J.; Mavuso, W. W.; Ncokazi, K. K. Biochemistry 2001, 40, 204-213.
7. Hempelmann, E.; Egan, T. J. Trends Parasitol. 2002, 18, 11.
8. Lowenstam, H. A.; Weiner, S. On Biomineralization; Oxford University Press: New York, 1989.
9. Wellems, T. E.; Plowe, C. V. J. Inf. Dis. 2001, 184, 770-776.
10. Bray, P. G.; Mungthin, M.; Ridley, R. G.; Ward, S. A. Mol. Pharmacol. 1998, 54, 170-179.
11. Ginsburg, H.; Geary, T. G. Biochem. Pharmacol. 1987, 36, 1567-1576. and citations therein.
12. Ginssburg, H.; Nissany, E.; Kruglak, M. Biochem. Pharmacol. 1989, 38, 2645-2654.
13. Gray, T. G.; Divo, A. D.; Jensen, J. B.; Zangwill, M.; Ginssburg, H. Biochem. Pharmacol. 1990, 40, 685-691.
14. a3 of the secondary aniline amine nitrogen is estimated at 5.0 (refs 73-75). Calculating the extent of ionization of weak base in the two pH environments using the Henderson-Hasselblach equation for the various amines of chloroquine, we obtain for physiological pH = 7.4: 0.4% (5.0), 83.4% (8.1), 99.8% (10.2), and in the acidic vacuole pH = 4.8: 61.3% (5.0), 99.9% (8.1), and 100% (10.2).
15. Yayon, A.; Cabantchik, Z. I.; Ginsburg, H. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 2784-2788.
16. Gary, T. G.; Jensen, J. B.; Ginssburg, H. Biochem. Pharmacol. 1986, 35, 3805-3812.
17. Bray, P. G.; Boulter, M. K.; Ritchie, G. Y.; Ward, S. A. Mol. Biochem. Parasitol. 1994, 63, 87-94.
18. Hawley, S. R.; Bray, P. G.; Park, B. K.; Ward, S. A. Mol. Biochem. Parasitol. 1996, 80, 15-25.
19. Hawley, S. R.; Bray, P. G.; O'Neill, P. M.; Park, K.; Ward, S. A. Biochem. Pharmacol. 1996, 52, 723-733.
20. Pagola, S.; Stephens, P. W.; Bohle, D. S.; Kosar, A. D.; Madsen, S. K. Nature 2000, 404, 307.
21. Hawley, S. R.; Bray, P. G.; Mungthin, M.; Atkinson, J. D.; O'Neill, P. M.; Ward, S. A. Antimicrob. Agents Chemother. 1998, 42, 682-686.
22. Dorn, A.; Vippagunta, S. R.; Matile, H.; Jaquet, C.; Vennerstrom, J. L.; Ridley, R. G. Biochem. Pharmacol. 1998, 55, 727-736.
23. Macomber, P. B.; Sprinz, H.; Tousimis, A. J. Nature 1967, 214, 937.
24. Sullivan, D. J. J.; Matile, H.; Ridley, R. G.; Goldberg, D. E. J. Biol. Chem. 1998, 273, 31103-31107.
25. Sullivan, D. J. J.; Y., G. I.; Russell, D. G.; Goldberg, D. E. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 11865-11870.
26. The reported cell constants are a = 12.20 Å, b = 14.68 Å, c = 8.04 Å, a = 90.2°, β = 96.8°, γ = 97.9°, space group P1.
27. Egan, T. J.; Mavuso, W. W.; Ross, D. C.; Marques, H. M. J. Inorg. Biochem. 1997, 68, 137-145.
28. Chen, M. M.; Shi, L.; Sullivan, D. J. J. Mol., Biochem. Parasitol. 2001, 113, 1.
29. Egan, T. J.; Ross, D. C.; Adams, P. A. FEBS Lett. 1994, 352, 54-57.
30. Hartman, P.; Perdok, W. G. Acta Crystallogr. 1955, 8, 49.
31. Hartman, P.; Perdok, W. G. Acta Crystallogr. 1955, 8, 525.
32. Hartman, P. Crystal Growth: An Introduction; North-Holland Publishing Co.: Amsterdam, 1973.
33. Hartman, P.; Benema, P. J. Cryst. Growth 1980, 49, 145.
34. Berkovitch-Yellin, Z. J. Am. Chem. Soc. 1985, 107, 3375.
35. Weissbuch, I.; Shimon, L. J. W.; Addadi, L.; Berkovitch-Yellin, Z.; Lahav, M.; Leiserowitz, L. Israel J. Chem. 1985, 25, 353.
36. Weissbuch, I.; Berkovitch-Yellin, Z.; Leiserowitz, L.; Lahav, M. Isr. J. Chem. 1985, 25, 362.
37. Boek, E. S.; Feil, D.; Briels, W. J.; Bennema, P. J. Cryst. Growth 1991, 114, 389-410.
38. Docherty, R.; Meenan, P. In Molecular Modeling Applications in Crystallization; Myerson, A. S., Ed.; Cambridge University Press: 1999; p 106.
39. Woensdregt, C. F. Faraday Discuss. 1993, 95, 97.
40. Weissbuch, I.; Addadi, L.; Lahav, M.; Leiserowitz, L. Science 1991, 253, 637-645.
41. Weissbuch, I.; Popovitz-Biro, R.; Lahav, M.; Leiserowitz, L. Acta Crystallogr. B 1995, 51, 115-148.
42. Cerius2 v. 4.5, Accelrys Inc., San Diego, CA, 2000.
43. {h, k, l} denotes both (h, k, l) and (-h, -k, -l) faces.
44. To reduce errors due to the possibility that the specimen crystals may not lie exactly parallel to the plane of the {100} face we had made use of crystals with different azimuths, as well as the projected thickness of the {011} face.
45. Extended polymer chains would most likely lie parallel to the long axis of the crystal, in this case the c-axis, even though such a crystal would grow by side-to-side juxtaposition of the polymer chains. Since such chains will not be of the same length their ends cannot form a smooth obliquely oriented {011} face.
46. Weissbuch, I.; Leiserowitz, L.; Lahav, M. Adv. Mater. 1994, 6, 953-956.
47. Knight, C. A.; Cheng, C. C.; Devries, A. L. Biophys. J. 1991, 59, 409-418.
48. Shimon, L. J. W.; Vaida, M.; Addadi, L.; Lahav, M.; Leiserowitz, L. J. Am. Chem. Soc. 1990, 112, 6215.
49. Davey, R. J.; Milisavljevic, B.; Bourne, J. R. J. Phys. Chem. 1988, 92, 2032.
50. Wireko, F. C.; Shimon, L. J. W.; Frolow, F.; Berkovitch-Yellin, Z.; Lahav, M.; Leiserowitz, L. J. Phys. Chem. 1987, 91, 472.
51. Hussain, M.; Anwar, J. J. Am. Chem. Soc. 1999, 121, 8583-8591.
52. Alonso, C.; Eliash, R.; Jensen, T. R.; Kjaer, K.; Lahav, M.; Leiserowitz, L. J. Am. Chem. Soc. 2001, 123, 10105-10106.
53. Berkovitch-Yellin, Z.; Leiserowitz, L. Acta Crystallogr. 1984, B40, 159.
54. Bernstein, J.; Etter, M. C.; Leiserowitz, L. Structure Correlation; Buergi, H.-B. and Dunitz, J. D., Ed.; VCH: Weinheim, 1994; Vol. 2.
55. 2(carboxylate) hydrogen bond, which occurs in several zwitterionic α-amino acid crystal structures, must be no less than 6 kcal/mol.
56. Steiner, T. Angew. Chem., Int. Ed. 2002, 41, 48-76. In this review OH···C=C interactions were referred to, rather than NH···C=C.
57. It is noteworthy that the γ-crystalline form of glycine, which is in a zwitterionic state, is obtained from an aqueous solution of glycine made acidic with acetic acid or basic with ammonium hydroxide (ref 76).
58. 50 (effective dose 50) is the amount of material required to produce a specified effect in 50% of an animal population.
59. Egan, T. J.; Hunter, R.; Kaschula, C. H.; Marques, H. M.; Misplon, A.; Walden, J. J. Med. Chem. 2000, 43, 283-291.
60. 50 values (ref 58) for drug-mediated crystal inhibition in vitro experiments was usually higher than for in-vivo experiments (using chloroquine sensitive parasites). This difference may be attributed to the ability of the molecule to accumulate within the food vacuole, increasing its local concentration at the target site.
61. Thermodynamic parameters for various quinolines were also calculated for neutral pH ∼ 7.5 by Egan et al. (refs 27 and 77) in 407% DMSO, while Dorn et al. (ref 22) measured at pH ∼ 6.5 in water, with similar results.
62. Ridley, R. G.; Hofheinz, W.; Matile, H.; Aquet, C.; Dorn, A.; Masciardi, R.; Jolidon, S.; Richter, W. F.; Guenzi, A.; Girometta, M.-A.; Urwyler, H.; Huber, W.; Thaithong, S.; Peters, W. Antimicrob. Agent. Chemother. 1996, 40, 1846-1854.
63. 50 values.
64. Warhurst, D. C. Biochem. Pharmacol. 1981, 30, 3323-3327.
65. Jacquemain, D.; Wolf, S. G.; Levieiller, F.; Frolow, F.; Eisenstein, M.; Lahav, M.; Leiserowitz, L. J. Am. Chem. Soc. 1992, 114, 9983-9989. In this reference the net charge of -0.14e units on F atoms was determined experimentally from a deformation electron density analysis of low-temperature X-ray diffraction data. The net charge on the H atom is about +0.06 e units.
66. Addadi, L.; Berkovitch-Yellin, Z.; Weissbuch, I.; Lahav, M.; Leiserowitz, L. Topics in Stereochemistry; J. Wiley & Sons: New York, 1986; Vol. 16.
67. 3 and H groups attached to the asymmetric C atom, does not appear to embody poor intramolecular contacts, nor introduce a noticeable change in intermolecular contacts.
68. 3. However, whether the X-ray powder diffraction analysis can reveal atomic disorder between the vinyl and methyl groups as low as 5-10% is a moot point.
69. Moreau, S.; Perly, B.; Biguet, J. Biochimie 1982, 64, 1015-1025.
70. Raynes, K.; Foley, M.; Tilley, L.; Deaddy, L. W. Biochem. Pharmacol. 1996, 52, 551-559.
71. Ridley, R. G.; Matile, H.; Aquet, C.; Dorn, A.; Hofheinz, W.; Leupin, W.; Masciardi, R.; Theil, F.-P.; Richter, W. F.; Girometta, M.-A.; Guenzi, A.; Urwyler, H.; Gocke, E.; Potthast, J.-M.; Csato, M.; Thomas, A.; Peters, W. Antimicrob. Agent. Chemother. 1997, 41, 677-686.
72. Ismail, F. M. d.; Dascombe, M. J.; Carr, P.; Merette, S. A. M.; Rouault, P. J. Pharm. Pharmacol. 1998, 50.
73. Streitwieser, A.; Heathcock, C. H.; Kosower, E. M. Introduction to Organic Chemistry; 4th ed.; Prentice Hall: Upper Saddle River, NJ, 1998.
74. a, http://www.chem.wisc.edu/ areas/reich/pkatable/index.htm, 2002.
75. a Harvard, http://daeiris.harvard.edu/ DavidEvans.html, 1997.
76. Iitaka, Y. Acta Crystallogr. 1961, 14, 1-10.
77. Egan, T. J.; Hempelmann, E.; Mavuso, W. W. J. Inorg. Biochem. 1999, 73, 101-107.
78. De, D.; Krogstad, F. M.; Byers, L. D.; Krogstad, D. J. J. Med. Chem. 1998, 41, 4918-4926.